This company listing is no longer activeThis company may still be operating, however this listing is no longer active. Find out why through their latest events.See Latest EventsCirca Group（8U5）株式概要サーカ・グループASは、オーストラリア、フランス、イギリス、ベルギー、ノルウェーで生化学製品の製造・販売を行っている。 詳細8U5 ファンダメンタル分析スノーフレーク・スコア評価0/6将来の成長0/6過去の実績0/6財務の健全性3/6配当金0/6リスク分析キャッシュランウェイが1年未満である 過去5年間で収益は年間18.4%減少しました。 意味のある時価総額がありません ( €78M )株式の流動性は非常に低い +1 さらなるリスクすべてのリスクチェックを見る8U5 Community Fair Values Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.Your Fair Value€Current Price€0.028374.6% 割高 内在価値ディスカウントGrowth estimate overAnnual revenue growth rate5 Yearstime period%/yrDecreaseIncreasePastFuture-7m4m2016201920222025202620282031Revenue €390.3kEarnings €37.1kAdvancedSet Fair ValueView all narrativesFeatured narrative•Materials opportunityUpside Gold2 months ago author updated this narrativeSTFair Value from stuart_robertsCA$5.0768.0% 割安 内在価値ディスカウントAn Undervalued 3.3Moz Gold Project in CanadaKey takeaways Upside Gold is developing the Kena Gold Project, near the town of Nelson in the Kootenays region of southern British Columbia. Kena hosts a historical gold resource of 3.33 million ounces (561,000 ounces Indicated and 2.77 million ounces Inferred) across a 10,200-hectare land package.Read full narrative14.8kusers have viewed this narrative41users have liked this narrative1users have commented on this narrative284users have followed this narrativeRead narrativeCirca Group AS 競合他社Bio-GateSymbol: DB:BIG1Market cap: €7.1mBRAIN BiotechSymbol: XTRA:BNNMarket cap: €71.0mNabaltecSymbol: XTRA:NTGMarket cap: €92.8mH&R GmbH KGaASymbol: XTRA:2HRAMarket cap: €173.1m価格と性能株価の高値、安値、推移の概要Circa Group過去の株価現在の株価NOK 0.02852週高値NOK 0.3052週安値NOK 0.0078ベータ-0.101ヶ月の変化0%3ヶ月変化53.85%1年変化-90.31%3年間の変化-96.31%5年間の変化n/aIPOからの変化-98.25%最新ニュースお知らせ • Sep 10Circa Group AS Announces Resignation of Lars P. Sperre as DirectorDirector Lars P. Sperre has informed Circa Group AS that he has accepted a new full-time role which requires him to resign from the director role with the company. Circa Group AS will continue with the remaining board consisting of six directors, which is in accordance with the company’s article of association and will not engage in a replacement process for the time being.Reported Earnings • Aug 23Second quarter 2024 earnings released: €0.02 loss per share (vs €0.009 loss in 2Q 2023)Second quarter 2024 results: €0.02 loss per share (further deteriorated from €0.009 loss in 2Q 2023). Net loss: €2.08m (loss widened 97% from 2Q 2023).New Risk • Jul 22New major risk - Market cap sizeThe company's market capitalization is less than US$10m. Market cap: €7.97m (US$8.67m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-€29m free cash flow). Share price has been highly volatile over the past 3 months (22% average weekly change). Earnings have declined by 18% per year over the past 5 years. Market cap is less than US$10m (€7.97m market cap, or US$8.67m). Minor Risk Revenue is less than US$5m (€1.6m revenue, or US$1.8m).Board Change • Jun 16No independent directorsFollowing the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 8 non-independent directors. Director Simon Powell was the last director to join the board, commencing their role in 2024. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model.お知らせ • May 29Circa Group AS Approves the Election of Simon Powell as A Board MemberCirca Group AS at its AGM, held on May 28, 2024, approved the election of Simon Powell as a board member for a two year period.Reported Earnings • May 17First quarter 2024 earnings released: €0.02 loss per share (vs €0.013 loss in 1Q 2023)First quarter 2024 results: €0.02 loss per share (further deteriorated from €0.013 loss in 1Q 2023). Net loss: €1.94m (loss widened 21% from 1Q 2023).最新情報をもっと見るRecent updatesお知らせ • Sep 10Circa Group AS Announces Resignation of Lars P. Sperre as DirectorDirector Lars P. Sperre has informed Circa Group AS that he has accepted a new full-time role which requires him to resign from the director role with the company. Circa Group AS will continue with the remaining board consisting of six directors, which is in accordance with the company’s article of association and will not engage in a replacement process for the time being.Reported Earnings • Aug 23Second quarter 2024 earnings released: €0.02 loss per share (vs €0.009 loss in 2Q 2023)Second quarter 2024 results: €0.02 loss per share (further deteriorated from €0.009 loss in 2Q 2023). Net loss: €2.08m (loss widened 97% from 2Q 2023).New Risk • Jul 22New major risk - Market cap sizeThe company's market capitalization is less than US$10m. Market cap: €7.97m (US$8.67m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-€29m free cash flow). Share price has been highly volatile over the past 3 months (22% average weekly change). Earnings have declined by 18% per year over the past 5 years. Market cap is less than US$10m (€7.97m market cap, or US$8.67m). Minor Risk Revenue is less than US$5m (€1.6m revenue, or US$1.8m).Board Change • Jun 16No independent directorsFollowing the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 8 non-independent directors. Director Simon Powell was the last director to join the board, commencing their role in 2024. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model.お知らせ • May 29Circa Group AS Approves the Election of Simon Powell as A Board MemberCirca Group AS at its AGM, held on May 28, 2024, approved the election of Simon Powell as a board member for a two year period.Reported Earnings • May 17First quarter 2024 earnings released: €0.02 loss per share (vs €0.013 loss in 1Q 2023)First quarter 2024 results: €0.02 loss per share (further deteriorated from €0.013 loss in 1Q 2023). Net loss: €1.94m (loss widened 21% from 1Q 2023).お知らせ • Apr 20Circa Group as Announces Appointment of Erik Berger as Interim CFO, Effective on April 22, 2024Circa Group AS has hired Erik Berger starting as interim CFO following CFO Tone Leivestad's decision to resign in March. Erik Berger will join Circa on 22 April 2024 and will be based in the Oslo corporate office. Erik Berger comes with a senior background and is experienced in finance, raising capital, business strategy and performance. Erik's career has spanned various countries and sectors, including oil and gas and renewables. He has an MBA from French business school Ecole de Management Lyon.Reported Earnings • Feb 16Full year 2023 earnings released: €0.05 loss per share (vs €0.049 loss in FY 2022)Full year 2023 results: €0.05 loss per share. Net loss: €5.83m (loss narrowed 2.5% from FY 2022).New Risk • Feb 15New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of German stocks, typically moving 7.5% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-€27m free cash flow). Earnings have declined by 21% per year over the past 5 years. Minor Risks Share price has been volatile over the past 3 months (7.5% average weekly change). Revenue is less than US$5m (€1.8m revenue, or US$2.0m). Market cap is less than US$100m (€24.2m market cap, or US$26.0m).お知らせ • Nov 24Circa Group AS Announces Chief Executive Officer Changes, Effective 1 January 2024Circa Group AS announced the appointment of Bertel Karlstedt as the company's next Chief Executive Officer (CEO), effective 1 January 2024. Bertel joins Circa from Valmet Technologies Oy and Circa's industrial partner for the Furacell technology and the ReSolute project. This experience gives Bertel a unique head start and insight into ReSolute and Circa's longer-term strategic vision. Bertel Karlstedt brings 35 years of experience from a successful industrial career where he was responsible for businesses exceeding EUR1bn turnover. In his current role, he is assisting Valmet in the transition to the next generation of leaders, having been the President of Valmet's EUR 1 billion global Pulp and Energy business from 2015 to 2022. Before Valmet, Bertel was CEO of Nordkalk Oyj for almost 10 years. He was CEO of Metso Paper and President of Valmet-Rauma & Metso Paper's Paper Making business, with units across the globe and significant production in China. Bertel Karlstedt succeeds Tony Duncan, the Co-founder of Circa who has served as CEO since 2006. Under Tony's leadership, Circa has developed from an innovativeAustralian patented prototype company into a well-established, Euronext Growth listed, renewable chemicals company.お知らせ • Nov 14+ 4 more updatesCirca Group AS to Report Q3, 2024 Results on Nov 14, 2024Circa Group AS announced that they will report Q3, 2024 results on Nov 14, 2024Reported Earnings • Nov 11Third quarter 2023 earnings released: €0.01 loss per share (vs €0.013 loss in 3Q 2022)Third quarter 2023 results: €0.01 loss per share. Net loss: €1.61m (flat on 3Q 2022).New Risk • Aug 20New major risk - Revenue and earnings growthEarnings have declined by 16% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 16% per year over the past 5 years. Minor Risks Currently unprofitable and not forecast to become profitable next year (€4.1m net loss next year). Share price has been volatile over the past 3 months (7.9% average weekly change). Revenue is less than US$5m (€1.7m revenue, or US$1.8m). Market cap is less than US$100m (€40.4m market cap, or US$43.9m).Reported Earnings • Aug 18Second quarter 2023 earnings releasedSecond quarter 2023 results: Net loss: €1.05m (loss narrowed 48% from 2Q 2022).New Risk • Jul 07New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of German stocks, typically moving 6.9% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Currently unprofitable and not forecast to become profitable next year (€5.3m net loss next year). Share price has been volatile over the past 3 months (6.9% average weekly change). Revenue is less than US$5m (€1.2m revenue, or US$1.3m). Market cap is less than US$100m (€39.3m market cap, or US$43.0m).お知らせ • Jul 07Circa Group AS Applies for Patent for Two New Solvents for Co2 Capture ProcessCirca Group AS has applied for patents for two new solvents for CO2 capture processes. As both the interest and the urgency to capture and transform carbon dioxide (CO2) emissions increases, Circa has developed two new CO2 solvents from its platform molecule, levoglucosenone (LGO). The two new solvents named Furatech:1 and Furatech:2 are the product of 12 months of development and testing across a range of new LGO-based molecules within Circa's R&D team. The Furatech products have been designed to be used in several current CO2 capture processes and discussions are underway about further optimisation with engineering partners. With the ReSolute plant commissioning planned for mid-2024, further testing and trialling of Furatech:1 and Furatech:2 will continue in parallel.お知らせ • May 10Circa Group AS Announces Management ChangesAs part of the continuous process to strengthen the organisation for the ongoing industrialisation and growth of Circa, the board of directors announced that Dr. Steve Döring has been appointed as the next CEO of Circa Group AS. The engagement of Dr. Döring is part of a succession plan following Tony Duncan's enormous efforts in the CEO role for Circa in over a decade. Tony Duncan will continue in the CEO role up to the transition with Dr. Döring which is scheduled to take place early in Fourth Quarter 2023. Dr. Döring succeeds Tony Duncan who is co-founder of Circa and has been serving as CEO since 2006. During his time as CEO, Circa has developed from an Australian development initiative into a well-established, Euronext Growth listed, renewable chemicals company with a well-known brand internationally and strong growth ambitions. Following the hand-over of the CEO role, Circa will propose to the shareholders to elect Tony Duncan to the board of directors of Circa to continue his engagement for the development of the company.Reported Earnings • Apr 23Full year 2022 earnings released: €0.049 loss per share (vs €0.058 loss in FY 2021)Full year 2022 results: €0.049 loss per share (improved from €0.058 loss in FY 2021). Net loss: €5.97m (loss narrowed 15% from FY 2021). Revenue is forecast to grow 158% p.a. on average during the next 2 years, compared to a 1.7% growth forecast for the Chemicals industry in Germany.Reported Earnings • Feb 17Full year 2022 earnings released: €0.049 loss per share (vs €0.058 loss in FY 2021)Full year 2022 results: €0.049 loss per share (improved from €0.058 loss in FY 2021). Net loss: €5.97m (loss narrowed 15% from FY 2021). Revenue is forecast to grow 158% p.a. on average during the next 2 years, compared to a 1.5% growth forecast for the Chemicals industry in Germany.Reported Earnings • Nov 19Third quarter 2022 earnings released: €0.013 loss per share (vs €0.013 loss in 3Q 2021)Third quarter 2022 results: €0.013 loss per share (in line with 3Q 2021). Net loss: €1.60m (flat on 3Q 2021). Revenue is forecast to grow 131% p.a. on average during the next 2 years, while revenues in the Chemicals industry in Germany are expected to remain flat.お知らせ • Nov 19+ 5 more updatesCirca Group AS, Annual General Meeting, May 25, 2023Circa Group AS, Annual General Meeting, May 25, 2023.Board Change • Nov 16No independent directorsFollowing the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 7 non-independent directors. Director Martin Laudenbach was the last director to join the board, commencing their role in 2022. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model.Reported Earnings • Aug 25Second quarter 2022 earnings releasedSecond quarter 2022 results: Net loss: €2.02m (loss widened 31% from 2Q 2021). Over the next year, revenue is forecast to grow 27%, compared to a 2.4% growth forecast for the Chemicals industry in Germany.お知らせ • Jul 07Circa Group AS Announces Board AppointmentsThe general assembly of Circa Group AS was held on 2 June 2022 and two new members were elected to the board of directors: Mr. Martin Laudenbach and Ms Elise Fahlén. Martin Laudenbach has extensive experience in the international chemical industry from serving in senior positions at BASF and Solvay. He currently works as a professional advisor and holds various director positions including in the Polish chemical group CIECH S.A. Elise Fahlén has a strong background in venture capital and private equity investments and is currently employed as an Investment Manager at the venture capital investment branch of the H&M Group in Stockholm. She also holds director positions among others in the Swedish stock listed investment company First Venture Sweden AB. The Circa Group board of directors consists of the following board members: Lars Sperre (chair); Gregory Court; Elise Fahlén; James Alan Henneberry; Martin Laudenbach; Rune Sollie; Trond Stangeby.Reported Earnings • May 25First quarter 2022 earnings releasedFirst quarter 2022 results: €0.009 loss per share. Net loss: €1.05m (loss narrowed 69% from 1Q 2021). Over the next year, revenue is forecast to grow 15%, compared to a 6.4% growth forecast for the industry in Germany.Board Change • Apr 27No independent directorsFollowing the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 6 non-independent directors. Director Trond Stangeby was the last director to join the board, commencing their role in 2021. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model.Executive Departure • Sep 01Chief Financial Officer Peter Gome has left the companyOn the 1st of September, Peter Gome's tenure as Chief Financial Officer ended. As of June 2021, Peter still personally held 1.33m shares (€2.2m worth at the time). Peter is the only executive to leave the company over the last 12 months.株主還元8U5DE ChemicalsDE 市場7D0%-1.6%3.4%1Y-90.3%5.5%3.4%株主還元を見る業界別リターン: 8U5過去 1 年間で5.5 % の収益を上げたGerman Chemicals業界を下回りました。リターン対市場: 8U5は、過去 1 年間で3.4 % のリターンを上げたGerman市場を下回りました。価格変動Is 8U5's price volatile compared to industry and market?8U5 volatility8U5 Average Weekly Movementn/aChemicals Industry Average Movement5.7%Market Average Movement6.0%10% most volatile stocks in DE Market12.5%10% least volatile stocks in DE Market2.7%安定した株価: 8U5の株価は、 German市場と比較して過去 3 か月間で変動しています。時間の経過による変動: 過去 1 年間の8U5のボラティリティの変化を判断するには データが不十分です。会社概要設立従業員CEO（最高経営責任者ウェブサイト200617Bertel Karlstedtwww.circa-group.comサーカ・グループASは、オーストラリア、フランス、イギリス、ベルギー、ノルウェーでバイオ化学製品の製造・販売を行っている。同社は、非食糧廃棄物バイオマスから価値を抽出し、Furacell製造プロセスを通じてバイオベースの化学品を製造している。製品には、極性非プロトン性溶媒Cyrene、レボグルコセノン誘導体などがある。同社の製品は、医薬品、農薬、香料、エレクトロニクス、電池、塗料、グラフェン、ポリマーなどの用途に使用されている。サーカ・グループASは2006年に設立され、ノルウェーのオスロに本社を置く。もっと見るCirca Group AS 基礎のまとめCirca Group の収益と売上を時価総額と比較するとどうか。8U5 基礎統計学時価総額€6.63m収益（TTM）-€7.34m売上高(TTM)€1.19m5.6xP/Sレシオ-0.9xPER（株価収益率8U5 は割高か？公正価値と評価分析を参照収益と収入最新の決算報告書（TTM）に基づく主な収益性統計8U5 損益計算書（TTM）収益€1.19m売上原価€448.00k売上総利益€739.00kその他の費用€8.08m収益-€7.34m直近の収益報告Jun 30, 2024次回決算日該当なし一株当たり利益（EPS）-0.06グロス・マージン62.26%純利益率-618.53%有利子負債／自己資本比率0%8U5 の長期的なパフォーマンスは？過去の実績と比較を見るView Valuation企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2024/12/17 05:39終値2024/10/07 00:00収益2024/06/30年間収益2023/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Circa Group AS 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。2 アナリスト機関Kenneth SivertsenPareto SecuritiesCarl Jørgen FlaenPareto Securities
Featured narrative•Materials opportunityUpside Gold2 months ago author updated this narrativeSTFair Value from stuart_robertsCA$5.0768.0% 割安 内在価値ディスカウントAn Undervalued 3.3Moz Gold Project in CanadaKey takeaways Upside Gold is developing the Kena Gold Project, near the town of Nelson in the Kootenays region of southern British Columbia. Kena hosts a historical gold resource of 3.33 million ounces (561,000 ounces Indicated and 2.77 million ounces Inferred) across a 10,200-hectare land package.Read full narrative14.8kusers have viewed this narrative41users have liked this narrative1users have commented on this narrative284users have followed this narrativeRead narrative
お知らせ • Sep 10Circa Group AS Announces Resignation of Lars P. Sperre as DirectorDirector Lars P. Sperre has informed Circa Group AS that he has accepted a new full-time role which requires him to resign from the director role with the company. Circa Group AS will continue with the remaining board consisting of six directors, which is in accordance with the company’s article of association and will not engage in a replacement process for the time being.
Reported Earnings • Aug 23Second quarter 2024 earnings released: €0.02 loss per share (vs €0.009 loss in 2Q 2023)Second quarter 2024 results: €0.02 loss per share (further deteriorated from €0.009 loss in 2Q 2023). Net loss: €2.08m (loss widened 97% from 2Q 2023).
New Risk • Jul 22New major risk - Market cap sizeThe company's market capitalization is less than US$10m. Market cap: €7.97m (US$8.67m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-€29m free cash flow). Share price has been highly volatile over the past 3 months (22% average weekly change). Earnings have declined by 18% per year over the past 5 years. Market cap is less than US$10m (€7.97m market cap, or US$8.67m). Minor Risk Revenue is less than US$5m (€1.6m revenue, or US$1.8m).
Board Change • Jun 16No independent directorsFollowing the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 8 non-independent directors. Director Simon Powell was the last director to join the board, commencing their role in 2024. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model.
お知らせ • May 29Circa Group AS Approves the Election of Simon Powell as A Board MemberCirca Group AS at its AGM, held on May 28, 2024, approved the election of Simon Powell as a board member for a two year period.
Reported Earnings • May 17First quarter 2024 earnings released: €0.02 loss per share (vs €0.013 loss in 1Q 2023)First quarter 2024 results: €0.02 loss per share (further deteriorated from €0.013 loss in 1Q 2023). Net loss: €1.94m (loss widened 21% from 1Q 2023).
お知らせ • Sep 10Circa Group AS Announces Resignation of Lars P. Sperre as DirectorDirector Lars P. Sperre has informed Circa Group AS that he has accepted a new full-time role which requires him to resign from the director role with the company. Circa Group AS will continue with the remaining board consisting of six directors, which is in accordance with the company’s article of association and will not engage in a replacement process for the time being.
Reported Earnings • Aug 23Second quarter 2024 earnings released: €0.02 loss per share (vs €0.009 loss in 2Q 2023)Second quarter 2024 results: €0.02 loss per share (further deteriorated from €0.009 loss in 2Q 2023). Net loss: €2.08m (loss widened 97% from 2Q 2023).
New Risk • Jul 22New major risk - Market cap sizeThe company's market capitalization is less than US$10m. Market cap: €7.97m (US$8.67m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-€29m free cash flow). Share price has been highly volatile over the past 3 months (22% average weekly change). Earnings have declined by 18% per year over the past 5 years. Market cap is less than US$10m (€7.97m market cap, or US$8.67m). Minor Risk Revenue is less than US$5m (€1.6m revenue, or US$1.8m).
Board Change • Jun 16No independent directorsFollowing the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 8 non-independent directors. Director Simon Powell was the last director to join the board, commencing their role in 2024. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model.
お知らせ • May 29Circa Group AS Approves the Election of Simon Powell as A Board MemberCirca Group AS at its AGM, held on May 28, 2024, approved the election of Simon Powell as a board member for a two year period.
Reported Earnings • May 17First quarter 2024 earnings released: €0.02 loss per share (vs €0.013 loss in 1Q 2023)First quarter 2024 results: €0.02 loss per share (further deteriorated from €0.013 loss in 1Q 2023). Net loss: €1.94m (loss widened 21% from 1Q 2023).
お知らせ • Apr 20Circa Group as Announces Appointment of Erik Berger as Interim CFO, Effective on April 22, 2024Circa Group AS has hired Erik Berger starting as interim CFO following CFO Tone Leivestad's decision to resign in March. Erik Berger will join Circa on 22 April 2024 and will be based in the Oslo corporate office. Erik Berger comes with a senior background and is experienced in finance, raising capital, business strategy and performance. Erik's career has spanned various countries and sectors, including oil and gas and renewables. He has an MBA from French business school Ecole de Management Lyon.
Reported Earnings • Feb 16Full year 2023 earnings released: €0.05 loss per share (vs €0.049 loss in FY 2022)Full year 2023 results: €0.05 loss per share. Net loss: €5.83m (loss narrowed 2.5% from FY 2022).
New Risk • Feb 15New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of German stocks, typically moving 7.5% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-€27m free cash flow). Earnings have declined by 21% per year over the past 5 years. Minor Risks Share price has been volatile over the past 3 months (7.5% average weekly change). Revenue is less than US$5m (€1.8m revenue, or US$2.0m). Market cap is less than US$100m (€24.2m market cap, or US$26.0m).
お知らせ • Nov 24Circa Group AS Announces Chief Executive Officer Changes, Effective 1 January 2024Circa Group AS announced the appointment of Bertel Karlstedt as the company's next Chief Executive Officer (CEO), effective 1 January 2024. Bertel joins Circa from Valmet Technologies Oy and Circa's industrial partner for the Furacell technology and the ReSolute project. This experience gives Bertel a unique head start and insight into ReSolute and Circa's longer-term strategic vision. Bertel Karlstedt brings 35 years of experience from a successful industrial career where he was responsible for businesses exceeding EUR1bn turnover. In his current role, he is assisting Valmet in the transition to the next generation of leaders, having been the President of Valmet's EUR 1 billion global Pulp and Energy business from 2015 to 2022. Before Valmet, Bertel was CEO of Nordkalk Oyj for almost 10 years. He was CEO of Metso Paper and President of Valmet-Rauma & Metso Paper's Paper Making business, with units across the globe and significant production in China. Bertel Karlstedt succeeds Tony Duncan, the Co-founder of Circa who has served as CEO since 2006. Under Tony's leadership, Circa has developed from an innovativeAustralian patented prototype company into a well-established, Euronext Growth listed, renewable chemicals company.
お知らせ • Nov 14+ 4 more updatesCirca Group AS to Report Q3, 2024 Results on Nov 14, 2024Circa Group AS announced that they will report Q3, 2024 results on Nov 14, 2024
Reported Earnings • Nov 11Third quarter 2023 earnings released: €0.01 loss per share (vs €0.013 loss in 3Q 2022)Third quarter 2023 results: €0.01 loss per share. Net loss: €1.61m (flat on 3Q 2022).
New Risk • Aug 20New major risk - Revenue and earnings growthEarnings have declined by 16% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 16% per year over the past 5 years. Minor Risks Currently unprofitable and not forecast to become profitable next year (€4.1m net loss next year). Share price has been volatile over the past 3 months (7.9% average weekly change). Revenue is less than US$5m (€1.7m revenue, or US$1.8m). Market cap is less than US$100m (€40.4m market cap, or US$43.9m).
Reported Earnings • Aug 18Second quarter 2023 earnings releasedSecond quarter 2023 results: Net loss: €1.05m (loss narrowed 48% from 2Q 2022).
New Risk • Jul 07New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of German stocks, typically moving 6.9% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Currently unprofitable and not forecast to become profitable next year (€5.3m net loss next year). Share price has been volatile over the past 3 months (6.9% average weekly change). Revenue is less than US$5m (€1.2m revenue, or US$1.3m). Market cap is less than US$100m (€39.3m market cap, or US$43.0m).
お知らせ • Jul 07Circa Group AS Applies for Patent for Two New Solvents for Co2 Capture ProcessCirca Group AS has applied for patents for two new solvents for CO2 capture processes. As both the interest and the urgency to capture and transform carbon dioxide (CO2) emissions increases, Circa has developed two new CO2 solvents from its platform molecule, levoglucosenone (LGO). The two new solvents named Furatech:1 and Furatech:2 are the product of 12 months of development and testing across a range of new LGO-based molecules within Circa's R&D team. The Furatech products have been designed to be used in several current CO2 capture processes and discussions are underway about further optimisation with engineering partners. With the ReSolute plant commissioning planned for mid-2024, further testing and trialling of Furatech:1 and Furatech:2 will continue in parallel.
お知らせ • May 10Circa Group AS Announces Management ChangesAs part of the continuous process to strengthen the organisation for the ongoing industrialisation and growth of Circa, the board of directors announced that Dr. Steve Döring has been appointed as the next CEO of Circa Group AS. The engagement of Dr. Döring is part of a succession plan following Tony Duncan's enormous efforts in the CEO role for Circa in over a decade. Tony Duncan will continue in the CEO role up to the transition with Dr. Döring which is scheduled to take place early in Fourth Quarter 2023. Dr. Döring succeeds Tony Duncan who is co-founder of Circa and has been serving as CEO since 2006. During his time as CEO, Circa has developed from an Australian development initiative into a well-established, Euronext Growth listed, renewable chemicals company with a well-known brand internationally and strong growth ambitions. Following the hand-over of the CEO role, Circa will propose to the shareholders to elect Tony Duncan to the board of directors of Circa to continue his engagement for the development of the company.
Reported Earnings • Apr 23Full year 2022 earnings released: €0.049 loss per share (vs €0.058 loss in FY 2021)Full year 2022 results: €0.049 loss per share (improved from €0.058 loss in FY 2021). Net loss: €5.97m (loss narrowed 15% from FY 2021). Revenue is forecast to grow 158% p.a. on average during the next 2 years, compared to a 1.7% growth forecast for the Chemicals industry in Germany.
Reported Earnings • Feb 17Full year 2022 earnings released: €0.049 loss per share (vs €0.058 loss in FY 2021)Full year 2022 results: €0.049 loss per share (improved from €0.058 loss in FY 2021). Net loss: €5.97m (loss narrowed 15% from FY 2021). Revenue is forecast to grow 158% p.a. on average during the next 2 years, compared to a 1.5% growth forecast for the Chemicals industry in Germany.
Reported Earnings • Nov 19Third quarter 2022 earnings released: €0.013 loss per share (vs €0.013 loss in 3Q 2021)Third quarter 2022 results: €0.013 loss per share (in line with 3Q 2021). Net loss: €1.60m (flat on 3Q 2021). Revenue is forecast to grow 131% p.a. on average during the next 2 years, while revenues in the Chemicals industry in Germany are expected to remain flat.
お知らせ • Nov 19+ 5 more updatesCirca Group AS, Annual General Meeting, May 25, 2023Circa Group AS, Annual General Meeting, May 25, 2023.
Board Change • Nov 16No independent directorsFollowing the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 7 non-independent directors. Director Martin Laudenbach was the last director to join the board, commencing their role in 2022. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model.
Reported Earnings • Aug 25Second quarter 2022 earnings releasedSecond quarter 2022 results: Net loss: €2.02m (loss widened 31% from 2Q 2021). Over the next year, revenue is forecast to grow 27%, compared to a 2.4% growth forecast for the Chemicals industry in Germany.
お知らせ • Jul 07Circa Group AS Announces Board AppointmentsThe general assembly of Circa Group AS was held on 2 June 2022 and two new members were elected to the board of directors: Mr. Martin Laudenbach and Ms Elise Fahlén. Martin Laudenbach has extensive experience in the international chemical industry from serving in senior positions at BASF and Solvay. He currently works as a professional advisor and holds various director positions including in the Polish chemical group CIECH S.A. Elise Fahlén has a strong background in venture capital and private equity investments and is currently employed as an Investment Manager at the venture capital investment branch of the H&M Group in Stockholm. She also holds director positions among others in the Swedish stock listed investment company First Venture Sweden AB. The Circa Group board of directors consists of the following board members: Lars Sperre (chair); Gregory Court; Elise Fahlén; James Alan Henneberry; Martin Laudenbach; Rune Sollie; Trond Stangeby.
Reported Earnings • May 25First quarter 2022 earnings releasedFirst quarter 2022 results: €0.009 loss per share. Net loss: €1.05m (loss narrowed 69% from 1Q 2021). Over the next year, revenue is forecast to grow 15%, compared to a 6.4% growth forecast for the industry in Germany.
Board Change • Apr 27No independent directorsFollowing the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 6 non-independent directors. Director Trond Stangeby was the last director to join the board, commencing their role in 2021. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model.
Executive Departure • Sep 01Chief Financial Officer Peter Gome has left the companyOn the 1st of September, Peter Gome's tenure as Chief Financial Officer ended. As of June 2021, Peter still personally held 1.33m shares (€2.2m worth at the time). Peter is the only executive to leave the company over the last 12 months.
